The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000070.3(CAPN3):c.1343G>T (p.Arg448Leu)

CA391999624

1180840 (ClinVar)

Gene: CAPN3 (HGNC:825)
Condition: autosomal recessive limb-girdle muscular dystrophy (MONDO:0015152)
Inheritance Mode: Autosomal recessive inheritance
UUID: b708dc64-c8c3-4823-a58b-ad4406c82733
Approved on: 2026-03-12
Published on: 2026-04-09

HGVS expressions

NM_000070.3:c.1343G>T
NM_000070.3(CAPN3):c.1343G>T (p.Arg448Leu)
NC_000015.10:g.42399641G>T
CM000677.2:g.42399641G>T
NC_000015.9:g.42691839G>T
CM000677.1:g.42691839G>T
NC_000015.8:g.40479131G>T
NG_008660.1:g.56539G>T
ENST00000349748.8:c.1199G>T
ENST00000357568.8:c.1343G>T
ENST00000397163.8:c.1343G>T
ENST00000466369.5:n.1852G>T
ENST00000483208.5:n.1574G>T
ENST00000495723.1:n.1574G>T
ENST00000549793.5:n.1574G>T
ENST00000638141.2:n.1214G>T
ENST00000673658.1:n.327G>T
ENST00000673705.1:c.298G>T
ENST00000318023.11:c.1199G>T
ENST00000349748.7:c.1199G>T
ENST00000357568.7:c.1343G>T
ENST00000397163.7:c.1343G>T
NM_000070.2:c.1343G>T
NM_024344.1:c.1343G>T
NM_173087.1:c.1199G>T
NM_024344.2:c.1343G>T
NM_173087.2:c.1199G>T
More

Likely Pathogenic

Met criteria codes 5
PM5 PP4 PP3 PM3_Strong PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CAPN3 Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_000070.3: c.1343G>T variant in CAPN3 is a missense variant predicted to cause the substitution of arginine by leucine at amino acid position 448, p.(Arg448Leu). This variant has been identified in at least six unrelated individuals with features consistent with LGMD (PMID: 25987458, 29797799, 22926650, 33250842, 32994280, 28403181), including in a homozygous state in one patient without reported consanguinity (0.5 pts, PMID: 32994280), confirmed in trans with a pathogenic variant in one patient (c.734dup p.(Ser246Ter), 1.0 pt, PMID: 28403181), and in unconfirmed phase with a pathogenic variant in one patient (c.2120A>G p.(Asp707Gly), 0.5 pts, PMID: 3299428). In two other patients, it was reported in unconfirmed phase with a variant classified as likely pathogenic by the VCEP (c.1319G>A p.(Arg440Gln), 0.25 pts, PMID: 33250842; c.2306G>C p.(Arg769Pro), 0.25 pts, PMID: 25987458) (PM3_Strong). At least one patient with this variant and a second presumed diagnostic CAPN3 allele displayed progressive limb girdle muscle weakness and reduced (<50%) or absent expression of calpain-3 protein in skeletal muscle, though the exact level was not specified (PMID: 22926650; PP4). This variant is absent from gnomAD v.4.1.0, meeting the criteria for PM2_Supporting. The computational predictor REVEL gives a score of 0.872, which is above the LGMD VCEP threshold of ≥0.70, evidence that correlates with impact to CAPN3 function. In addition, another missense variant at the same codon, c.1343G>A (p.Arg448His), has been classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 03/12/2026): PM3_Strong, PP4, PM2_Supporting, PP3, PM5.
Met criteria codes
PM5
Another missense variant at the same codon, c.1343G>A (p.Arg448His), has been classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5). c.1343G>A (p.Arg448His) is provisionally pathogenic without use of PM5 SpliceAI <0.5, no splice effect The Revel score for curated variant is >0.7 Not located near an exon-intron boundary.
PP4
At least one patient with this variant and a second presumed diagnostic CAPN3 allele displayed progressive limb girdle muscle weakness and reduced (<50%) or absent expression of calpain-3 protein in skeletal muscle, though the exact level was not specified (PMID: 22926650; PP4).
PP3
The computational predictor REVEL gives a score of 0.872, which is above the LGMD VCEP threshold of ≥0.70, evidence that correlates with impact to CAPN3 function.
PM3_Strong
This variant has been identified in at least six unrelated individuals with features consistent with LGMD (PMID: 25987458, 29797799, 22926650, 33250842, 32994280, 28403181), including in a homozygous state in one patient without reported consanguinity (0.5 pts, PMID: 32994280), confirmed in trans with a pathogenic variant in one patient (c.734dup p.(Ser246Ter), 1.0 pt, PMID: 28403181), and in unconfirmed phase with a pathogenic variant in one patient (c.2120A>G p.(Asp707Gly), 0.5 pts, PMID: 3299428). In two other patients, it was reported in unconfirmed phase with a variant classified as likely pathogenic by the VCEP (c.1319G>A p.(Arg440Gln), 0.25 pts, PMID: 33250842; c.2306G>C p.(Arg769Pro), 0.25 pts, PMID: 25987458) (PM3_Strong). co-occurrence predictions for variants in unconfirmed phase c.2120A>G (p.Asp707Gly): predicted on different haplotype in gnomAD v2 c.1319G>A (p.Arg440Gln): predicted on different haplotype in gnomAD v2 c.2306G>C p.(Arg769Pro): no prediction unscored cases: unknown phase with c.2243G>A (p.Arg748Gln) (not in VCI, Pathogenic in ClinVar) currently insufficient evidence to upgrade to PM3_Very Strong
PM2_Supporting
This variant is absent from gnomAD v.4.1.0, meeting the criteria for PM2_Supporting.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.